Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ

References

• Foote FW, Stewart FW. Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol. 1941;17(4):491–496.
   PubMedGoogle Scholar
• Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698–2708.
   PubMed Web of Science ®Google Scholar
• Page DL, Kidd TE, Dupont WD, et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22(12):1232–1239.
   PubMed Web of Science ®Google Scholar
• Lakhani S, Ellis IO, Schnitt SJ, et al. WHO Classification of Tumors of the Breast. 4th ed. Geneva, Switzerland: WHO Press; 2012.
   Google Scholar
• Frykberg ER. Lobular Carcinoma In Situ of the Breast. Breast J. 1999;5(5):296–303.
   PubMedGoogle Scholar
• Philpotts LE, Shaheen NA, Jain KS, et al. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology. 2000;216(3):831–837.
   PubMed Web of Science ®Google Scholar
• Jackman RJ, Birdwell RL, Ikeda DM. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology. 2002;224(2):548–554.
   PubMed Web of Science ®Google Scholar
• Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am Soc Prev Oncol. 2005;14(4):1008–1011.
   Google Scholar
• Esserman LE, Lamea L, Tanev S, et al. Should the extent of lobular neoplasia on core biopsy influence the decision for excision? Breast J. 2007;13(1):55–61.
   PubMed Web of Science ®Google Scholar
• Lavoué V, Roger CM, Poilblanc M, et al. Pure flat epithelial atypia (DIN 1a) on core needle biopsy: study of 60 biopsies with follow-up surgical excision. Breast Cancer Res Treat. 2011;125(1):121–126.
   PubMed Web of Science ®Google Scholar
• Mesurolle B, Perez JCH, Azzumea F, et al. Atypical ductal hyperplasia diagnosed at sonographically guided core needle biopsy: frequency, final surgical outcome, and factors associated with underestimation. AJR Am J Roentgenol. 2014;202(6):1389–1394.
   PubMed Web of Science ®Google Scholar
• Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer. 1996;78(7):1403–1416.
   PubMed Web of Science ®Google Scholar
• Li CI, Malone KE, Saltzman BS, et al. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001. Cancer. 2006;106(10):2104–2112.
   PubMed Web of Science ®Google Scholar
• Portschy PR, Marmor S, Nzara R, et al. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis. Ann Surg Oncol. 2013;20(10):3240–3246.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.
   PubMed Web of Science ®Google Scholar
• Simpson PT, Reis-Filho JS, Gale T, et al. Molecular evolution of breast cancer. J Pathol. 2005;205(2):248–254.
   PubMed Web of Science ®Google Scholar
• Lakhani SR, Collins N, Stratton MR, et al. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol. 1995;48(7):611–615.
   PubMed Web of Science ®Google Scholar
• Ansquer Y, Delaney S, Santulli P, et al. Risk of invasive breast cancer after lobular intra-epithelial neoplasia: review of the literature. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2010;36(7):604–609.
   Google Scholar
• Vos CB, Cleton-Jansen AM, Berx G, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 1997;76(9):1131–1133.
   PubMed Web of Science ®Google Scholar
• Hwang ES, Nyante SJ, Yi Chen Y, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer. 2004;100(12):2562–2572.
   PubMed Web of Science ®Google Scholar
• Aulmann S, Penzel R, Longerich T, et al. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat. 2008;107(3):331–335.
   PubMed Web of Science ®Google Scholar
• Wallace AS, Xiang D, Hockman L, et al. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2014;40(10):1245–1249.
   Google Scholar
• Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer. 1990;65(3):518–529.
   PubMed Web of Science ®Google Scholar
• Hong Z-J, Chu C-H, Fan H-L, et al. Factors predictive of breast cancer in open biopsy in cases with atypical ductal hyperplasia diagnosed by ultrasound-guided core needle biopsy. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2011;37(9):758–764.
   Google Scholar
• Schnitt SJ. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia–classification, pathologic features and clinical significance. Breast Cancer Res BCR. 2003;5(5):263–268.
   PubMed Web of Science ®Google Scholar
• Martel M, Barron-Rodriguez P, Tolgay Ocal I, et al. Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992–1999). Virchows Arch Int J Pathol. 2007;451(5):883–891.
   PubMed Web of Science ®Google Scholar
• Colin C, Devouassoux-Shisheboran M, Sardanelli F. Is breast cancer overdiagnosis also nested in pathologic misclassification? Radiology. 2014;273(3):652–655.
   PubMed Web of Science ®Google Scholar
• Elmore JG, Longton GM, Carney PA, et al. Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA. 2015;313(11):1122–1132.
   PubMed Web of Science ®Google Scholar
• Haagensen CD, Lane N, Lattes R, et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978;42(2):737–769.
   PubMed Web of Science ®Google Scholar
• Hussain M, Cunnick GH. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast–a review. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2011;37(4):279–289.
   Google Scholar
• Khoury T, Karabakhtsian RG, Mattson D, et al. Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases. Histopathology. 2014;64(7):981–993.
   PubMed Web of Science ®Google Scholar
• Jorns J, Sabel MS, Pang JC. Lobular neoplasia: morphology and management. Arch Pathol Lab Med. 2014;138(10):1344–1349.
   PubMed Web of Science ®Google Scholar
• Sullivan ME, Khan SA, Sullu Y, et al. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med. 2010;134(7):1024–1028.
   PubMed Web of Science ®Google Scholar
• Shin SJ, Lal A, De Vries S, et al. Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol. 2013;44(10):1998–2009.
   PubMed Web of Science ®Google Scholar
• Bagaria SP, Shamonki J, Kinnaird M, et al. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Ann Surg Oncol. 2011;18(7):1845–1851.
   PubMed Web of Science ®Google Scholar
• Breier G, Grosser M, Rezaei M. Endothelial cadherins in cancer. Cell Tissue Res. 2014;355(3):523–527.
   PubMed Web of Science ®Google Scholar
• Dabbs DJ, Schnitt SJ, Geyer FC, et al. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol. 2013;37(7):e1–11.
   Google Scholar
• Masannat YA, Bains SK, Pinder SE, et al. Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. Breast Edinb Scotl. 2013;22(2):194–196.
   PubMed Web of Science ®Google Scholar
• Cutuli B, De Lafontan B, Kirova Y, et al. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases. Radiat Oncol Lond Engl. 2015;10(1):110.
   PubMed Web of Science ®Google Scholar
• Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146–151.
   PubMed Web of Science ®Google Scholar
• London SJ, Connolly JL, Schnitt SJ, et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267(7):941–944.
   PubMed Web of Science ®Google Scholar
• Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71(4):1258–1265.
   PubMed Web of Science ®Google Scholar
• Andersen JA. Lobular carcinomain Situ of the breast:An approach to rational treatment. Cancer. 1977;39(6):2597–2602.
   PubMed Web of Science ®Google Scholar
• Chuba PJ, Hamre MR, Yap J, et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(24):5534–5541.
   PubMed Web of Science ®Google Scholar
• Lourenco AP, Khalil H, Sanford M, et al. High-risk lesions at MRI-guided breast biopsy: frequency and rate of underestimation. AJR Am J Roentgenol. 2014;203(3):682–686.
   PubMed Web of Science ®Google Scholar
• Heller SL, Hernandez O, Moy L. Radiologic-pathologic correlation at breast MR imaging: what is the appropriate management for high-risk lesions? Magn Reson Imaging Clin N Am. 2013;21(3):583–599.
   PubMed Web of Science ®Google Scholar
• Heller SL, Elias K, Gupta A, et al. Outcome of high-risk lesions at MRI-guided 9-gauge vacuum- assisted breast biopsy. AJR Am J Roentgenol. 2014;202(1):237–245.
   PubMed Web of Science ®Google Scholar
• Choi BB, Kim SH, Park CS, et al. Radiologic findings of lobular carcinoma in situ: mammography and ultrasonography. J Clin Ultrasound JCU. 2011;39(2):59–63.
   PubMed Web of Science ®Google Scholar
• Rendi MH, Dintzis SM, Lehman CD, et al. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol. 2012;19(3):914–921.
   PubMed Web of Science ®Google Scholar
• Scoggins M, Krishnamurthy S, Santiago L, et al. Lobular carcinoma in situ of the breast: clinical, radiological, and pathological correlation. Acad Radiol. 2013;20(4):463–470.
   PubMed Web of Science ®Google Scholar
• Buckley ES, Webster F, Hiller JE, et al. A systematic review of surgical biopsy for LCIS found at core needle biopsy - do we have the answer yet? Eur J Surg Oncol J. Eur Soc Surg Oncol Br Assoc Surg Oncol. 2014;40(2):168–175.
   PubMed Web of Science ®Google Scholar
• Allison KH, Eby PR, Kohr J, et al. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. Hum Pathol. 2011;42(1):41–50.
   PubMed Web of Science ®Google Scholar
• Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol. 2005;29(4):534–543.
   PubMed Web of Science ®Google Scholar
• Ancona A, Capodieci M, Galiano A, et al. Vacuum-assisted biopsy diagnosis of atypical ductal hyperplasia and patient management. Radiol Med. 2011;116(2):276–291.
   PubMed Web of Science ®Google Scholar
• Deshaies I, Provencher L, Jacob S, et al. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy. Breast Edinb Scotl. 2011;20(1):50–55.
   PubMed Web of Science ®Google Scholar
• Nguyen CV, Albarracin CT, Whitman GJ, et al. Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision. Ann Surg Oncol. 2011;18(3):752–761.
   PubMed Web of Science ®Google Scholar
• Villa A, Tagliafico A, Chiesa F, et al. Atypical ductal hyperplasia diagnosed at 11-gauge vacuum-assisted breast biopsy performed on suspicious clustered microcalcifications: could patients without residual microcalcifications be managed conservatively? AJR Am J Roentgenol. 2011;197(4):1012–1018.
   PubMed Web of Science ®Google Scholar
• Bendifallah S, Defert S, Chabbert-Buffet N, et al. Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: an external validation study. Eur J Cancer. 2012;48(1):30–36.
   PubMed Web of Science ®Google Scholar
• McGhan LJ, Pockaj BA, Wasif N, et al. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy? Ann Surg Oncol. 2012;19(10):3264–3269.
   PubMed Web of Science ®Google Scholar
• Sung JS, Malak SF, Bajaj P, et al. Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 2011;261(2):414–420.
   PubMed Web of Science ®Google Scholar
• King TA, Muhsen S, Patil S, et al. Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat. 2013;142(2):445–453.
   PubMed Web of Science ®Google Scholar
• Schwartz T, Cyr A, Margenthaler J. Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res. 2015;193(2):519–522.
   PubMed Web of Science ®Google Scholar
• Kohr JR, Eby PR, Allison KH, et al. Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology. 2010;255(3):723–730.
   PubMed Web of Science ®Google Scholar
• Sneige N, Lim SC, Whitman GJ, et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol. 2003;119(2):248–253.
   PubMed Web of Science ®Google Scholar
• Rosen PP, Kosloff C, Lieberman PH, et al. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978;2(3):225–251.
   PubMed Web of Science ®Google Scholar
• Rosen PP, Braun DW, Lyngholm B, et al. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy. Cancer. 1981;47(4):813–819.
   PubMed Web of Science ®Google Scholar
• Purdie CA, McLean D, Stormonth E, et al. Management of in situ lobular neoplasia detected on needle core biopsy of breast. J Clin Pathol. 2010;63(11):987–993.
   PubMed Web of Science ®Google Scholar
• Visvanathan K, Chlebowski RT, Hurley P, et al. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(19):3235–3258.
   PubMed Web of Science ®Google Scholar
• Shah-Khan MG, Geiger XJ, Reynolds C, et al. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol. 2012;19(10):3131–3138.
   PubMed Web of Science ®Google Scholar
• Wagoner MJ, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol. 2009;131(1):112–121.
   PubMed Web of Science ®Google Scholar
• Meroni S, Stefano M, Bozzini AC, et al. Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy. Eur Radiol. 2014;24(7):1651–1658.
   PubMed Web of Science ®Google Scholar
• Hsu -H-H, Yu J-C, Hsu G-C, et al. Atypical ductal hyperplasia of the breast diagnosed by ultrasonographically guided core needle biopsy. Ultraschall Med Stuttg Ger. 2012;33(5):447–454.
   PubMed Web of Science ®Google Scholar
• Uzan C, Mazouni C, Ferchiou M, et al. A model to predict the risk of upgrade to malignancy at surgery in atypical breast lesions discovered on percutaneous biopsy specimens. Ann Surg Oncol. 2013;20(9):2850–2857.
   PubMed Web of Science ®Google Scholar
• Caplain A, Drouet Y, Peyron M, et al. Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institution. Am J Surg. 2014;208(2):260–267.
   PubMed Web of Science ®Google Scholar
• McLaughlin CT, Neal CH, Helvie MA. Is the upgrade rate of atypical ductal hyperplasia diagnosed by core needle biopsy of calcifications different for digital and film-screen mammography? AJR Am J Roentgenol. 2014;203(4):917–922.
   PubMed Web of Science ®Google Scholar
• Youn I, Kim MJ, Moon HJ, et al. Absence of Residual Microcalcifications in Atypical Ductal Hyperplasia Diagnosed via Stereotactic Vacuum-Assisted Breast Biopsy: is Surgical Excision Obviated? J Breast Cancer. 2014;17(3):265–269.
   PubMed Web of Science ®Google Scholar
• Khoury T, Chen X, Wang D, et al. Nomogram to predict the likelihood of upgrade of atypical ductal hyperplasia diagnosed on a core needle biopsy in mammographically detected lesions. Histopathology. 2015;67(1):106–120.
   PubMed Web of Science ®Google Scholar
• Khoury T, Li Z, Sanati S, et al. The Risk of Upgrade for Atypical Ductal Hyperplasia Detected on MRI-Guided Biopsy: A Study of 100 Cases from Four Academic Institutions. Histopathology. 2015 Aug 20. [Epub ahead of print].
   Google Scholar
• Yu -C-C, Ueng S-H, Cheung Y-C, et al. Predictors of underestimation of malignancy after image-guided core needle biopsy diagnosis of flat epithelial atypia or atypical ductal hyperplasia. Breast J. 2015;21(3):224–232.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Clinical practice guidelines: breast cancer screening and diagnosis, version 1. 2014 [Internet]. Available from: (http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#detection)
   Google Scholar
• Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999;173(2):291–299.
   PubMed Web of Science ®Google Scholar
• Niell B, Specht M, Gerade B, et al. Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR Am J Roentgenol. 2012;199(4):929–935.
   PubMed Web of Science ®Google Scholar
• Provencher L, Jacob S, Côté G, et al. Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy. Radiology. 2012;263(1):43–52.
   PubMed Web of Science ®Google Scholar
• Atkins KA, Cohen MA, Nicholson B, et al. Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation. Radiology. 2013;269(2):340–347.
   PubMed Web of Science ®Google Scholar
• Downs-Kelly E, Bell D, Perkins GH, et al. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med. 2011;135(6):737–743.
   PubMed Web of Science ®Google Scholar
• Bianchi S, Bendinelli B, Castellano I, et al. Morphological parameters of lobular in situ neoplasia in stereotactic 11-gauge vacuum-assisted needle core biopsy do not predict the presence of malignancy on subsequent surgical excision. Histopathology. 2013;63(1):83–95.
   PubMed Web of Science ®Google Scholar
• Katsurada Y, Yoshida M, Maeshima AM, et al. Wide local extension and higher proliferation indices are characteristic features of symptomatic lobular neoplasias (LNs) and LNs with an early invasive component. Histopathology. 2014;64(7):994–1003.
   PubMed Web of Science ®Google Scholar
• Destounis SV, Murphy PF, Seifert PJ, et al. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. AJR Am J Roentgenol. 2012;198(2):281–287.
   PubMed Web of Science ®Google Scholar
• Ibrahim N, Bessissow A, Lalonde L, et al. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia? AJR Am J Roentgenol. 2012;198(2):288–291.
   PubMed Web of Science ®Google Scholar
• Lewis JL, Lee DY, Tartter PI. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Ann Surg Oncol. 2012;19(13):4124–4128.
   PubMed Web of Science ®Google Scholar
• Zhao C, Desouki MM, Florea A, et al. Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol. 2012;138(1):72–78.
   PubMed Web of Science ®Google Scholar
• Murray MP, Luedtke C, Liberman L, et al. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer. 2013;119(5):1073–1079.
   PubMed Web of Science ®Google Scholar
• Middleton LP, Sneige N, Coyne R, et al. Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med. 2014;3(3):492–499.
   PubMed Web of Science ®Google Scholar
• Linda A, Zuiani C, Bazzocchi M, et al. Borderline breast lesions diagnosed at core needle biopsy: can magnetic resonance mammography rule out associated malignancy? Preliminary results based on 79 surgically excised lesions. Breast Edinb Scotl. 2008;17(2):125–131.
   PubMed Web of Science ®Google Scholar
• Londero V, Zuiani C, Linda A, et al. High-Risk Breast Lesions at Imaging-Guided Needle Biopsy: usefulness of MRI for Treatment Decision. AJR Am J Roentgenol. 2012;199(2):W240–W250.
   Google Scholar
• Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75–89.
   PubMed Web of Science ®Google Scholar
• Friedlander LC, Roth SO, Gavenonis SC. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 2011;261(2):421–427.
   PubMed Web of Science ®Google Scholar
• Waters EA, McNeel TS, Stevens WM, et al. Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat. 2012;134(2):875–880.
   PubMed Web of Science ®Google Scholar
• Hartmann LC, Degnim AC, Santen RJ, et al. Atypical hyperplasia of the breast–risk assessment and management options. N Engl J Med. 2015;372(1):78–89.
   PubMed Web of Science ®Google Scholar
• Baker JL, Hasteh F, Blair SL. Atypical Ductal Hyperplasia at the Margin of Lumpectomy Performed for Early Stage Breast Cancer: is there Enough Evidence to Formulate Guidelines? Int J Surg Oncol. 2012;2012:297832.
   PubMedGoogle Scholar
• Sadek BT, Shenouda MN, Abi Raad RF, et al. Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary? Int J Radiat Oncol Biol Phys. 2013;87(4):726–730.
   PubMed Web of Science ®Google Scholar
• Li S, Liu J, Yang Y, et al. Impact of atypical hyperplasia at margins of breast-conserving surgery on the recurrence of breast cancer. J Cancer Res Clin Oncol. 2014;140(4):599–605.
   PubMed Web of Science ®Google Scholar
• D’Orsi Carl J, Sickles EA, Mendelson EB, et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. 5th ed. Reston, VA: American College of Radiology; 2013.
   Google Scholar
• McEvoy MP, Coopey SB, Mazzola E, et al. Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). Ann Surg Oncol. 2015;22(10):3346–3349.
   PubMed Web of Science ®Google Scholar
• Tice JA, Miglioretti DL, Li C-S, et al. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(28):3137–3143.
   PubMed Web of Science ®Google Scholar